Search
Cencora Inc
CORAdd to Watchlist
280.870USD
+9.590+3.54%
Market hours （ET）Quotes delayed by 15 min
54.65BMarket Cap
21.42P/E TTM
More Details of Cencora Inc Company
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Cencora Inc Info
Ticker SymbolCOR
Company nameCencora Inc
IPO dateMay 28, 1996
CEOMauch (Robert P)
Number of employees51000
Security typeOrdinary Share
Fiscal year-endMay 28
Address1 West First Avenue
CityCONSHOHOCKEN
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19428
Phone16107277000
Websitehttps://www.cencora.com/
Ticker SymbolCOR
IPO dateMay 28, 1996
CEOMauch (Robert P)
Company Executives of Cencora Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+0.94%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
1.07K
+51.91%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
168.00
-469.64%
Dr. Robert P. (Bob) Mauch, Ph.D.
Dr. Robert P. (Bob) Mauch, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. D. Mark Durcan
Mr. D. Mark Durcan
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+0.94%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
FAQs
Who are the top five shareholders of Cencora Inc?
The top five shareholders of Cencora Inc are: Ms. Elizabeth S. Campbell
How many institutions hold shares of Cencora Inc (COR)?
As of 2026Q1, 2508 institutions hold shares of Cencora Inc, with a combined market value of approximately 188.32M, accounting for 96.79% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 947639.00.
